Terms: = Germ cell tumor AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Prognosis
8 results:
1. Radiogenomic landscape: Assessment of specific phagocytosis regulators in lower-grade gliomas.
Maimaiti A; Abulaiti A; Tang B; Dilixiati Y; Li X; Yakufu S; Wang Y; Jiang L; Shao H
Exp Biol Med (Maywood); 2023 Dec; 248(23):2289-2303. PubMed ID: 38062999
[TBL] [Abstract] [Full Text] [Related]
2. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract] [Full Text] [Related]
3. Novel Nomograms as Aids for Predicting Recurrence and Survival in Chordoma Patients: A Retrospective Multicenter Study in mainland China.
Meng T; Huang R; Hu P; Yin H; Lin S; Qiao S; Wang R; Wang J; Cai Z; Huang Z; Cheng L; Song D
Spine (Phila Pa 1976); 2021 Jan; 46(1):E37-E47. PubMed ID: 32991511
[TBL] [Abstract] [Full Text] [Related]
4. Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors.
Terra Md SBSP; Xie Md PhD H; Boland Md JM; Mansfield Md AS; Molina Md PhD JR; Roden Md AC
Hum Pathol; 2019 Dec; 94():78-85. PubMed ID: 31499081
[TBL] [Abstract] [Full Text] [Related]
5. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic
Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540
[TBL] [Abstract] [Full Text] [Related]
6. Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
Jaber M; Ewelt C; Wölfer J; Brokinkel B; Thomas C; Hasselblatt M; Grauer O; Stummer W
Neurosurgery; 2019 Jun; 84(6):1214-1224. PubMed ID: 30107580
[TBL] [Abstract] [Full Text] [Related]
7. The importance of expressing PDCD4 and PDCD5 anti-oncogenes in glioma.
Wang C; Li JK; Li HZ; Gong HD
J Biol Regul Homeost Agents; 2018; 32(3):731-736. PubMed ID: 29921407
[TBL] [Abstract] [Full Text] [Related]
8. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.
Luo P; Wang X; Zhou J; Li L; Jing Z
Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233
[TBL] [Abstract] [Full Text] [Related]
